The polypill improved left ventricular ejection fraction, reduced hospitalizations, and enhanced quality of life in HFrEF patients over six months. The trial addressed polypharmacy challenges, showing ...
Discover the latest articles and news in related subjects. Figure 3: Lack of PARP does not affect the presence of single strand overhangs at the telomeres and in vitro telomerase activity. We ...